TT

T2 Biosystems

- NASDAQ:TTOO
Last Updated 2024-04-16

LinkedIn Profile

Access T2 Biosystems historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:ttoo 520960 Apr 14th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 13th, 2024 11:49PM Apr 13th, 2024 11:49PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 13th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 12th, 2024 11:41PM Apr 13th, 2024 12:14PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 12th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 11th, 2024 11:48PM Apr 12th, 2024 09:10AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 11th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 11th, 2024 12:36AM Apr 11th, 2024 11:55AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 10th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 9th, 2024 11:49PM Apr 10th, 2024 06:02PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 9th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 8th, 2024 11:59PM Apr 9th, 2024 10:44AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 8th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 8th, 2024 12:46AM Apr 8th, 2024 07:41PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 7th, 2024 12:00AM T2 Biosystems 10K 147.00 Open Apr 6th, 2024 11:54PM Apr 6th, 2024 11:54PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 6th, 2024 12:00AM T2 Biosystems 10K 147.00 Open Apr 5th, 2024 11:54PM Apr 5th, 2024 11:54PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Apr 5th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Apr 5th, 2024 12:52AM Apr 5th, 2024 12:52AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.